172 related articles for article (PubMed ID: 37822160)
1. FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing.
Li S; Chen Y; Xie Y; Zhan H; Zeng Y; Zeng K; Wang L; Zhan Z; Li C; Zhao L; Chen X; Tan Y; Wang Z; Bu J; Song Y; Deng F; Zhou A
Adv Sci (Weinh); 2023 Nov; 10(33):e2303561. PubMed ID: 37822160
[TBL] [Abstract][Full Text] [Related]
2. SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity.
Kim JH; Jeong K; Li J; Murphy JM; Vukadin L; Stone JK; Richard A; Tran J; Gillespie GY; Flemington EK; Sobol RW; Lim SS; Ahn EE
Nat Commun; 2021 Sep; 12(1):5551. PubMed ID: 34548489
[TBL] [Abstract][Full Text] [Related]
3. Alternative Splicing of the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) Is Regulated by RBFOX2 in Lymphoid Malignancies.
Cooper AM; Nutter CA; Kuyumcu-Martinez MN; Wright CW
Mol Cell Biol; 2022 May; 42(5):e0050321. PubMed ID: 35404107
[TBL] [Abstract][Full Text] [Related]
4. A FBXO7/EYA2-SCF
Shen JZ; Qiu Z; Wu Q; Zhang G; Harris R; Sun D; Rantala J; Barshop WD; Zhao L; Lv D; Won KA; Wohlschlegel J; Sangfelt O; Laman H; Rich JN; Spruck C
Mol Cell; 2022 Mar; 82(6):1123-1139.e8. PubMed ID: 35182481
[TBL] [Abstract][Full Text] [Related]
5. RBFOX2/GOLIM4 Splicing Axis Activates Vesicular Transport Pathway to Promote Nasopharyngeal Carcinogenesis.
Luo CL; Xu XC; Liu CJ; He S; Chen JR; Feng YC; Liu SQ; Peng W; Zhou YQ; Liu YX; Wei PP; Li B; Mai HQ; Xia XJ; Bei JX
Adv Sci (Weinh); 2021 Aug; 8(16):e2004852. PubMed ID: 34180133
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
Roy Burman D; Das S; Das C; Bhattacharya R
Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
[TBL] [Abstract][Full Text] [Related]
7. Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.
Teixeira FR; Randle SJ; Patel SP; Mevissen TE; Zenkeviciute G; Koide T; Komander D; Laman H
Biochem J; 2016 Oct; 473(20):3563-3580. PubMed ID: 27503909
[TBL] [Abstract][Full Text] [Related]
8. RBFOX2 alters splicing outcome in distinct binding modes with multiple protein partners.
Zhou D; Couture S; Scott MS; Abou Elela S
Nucleic Acids Res; 2021 Aug; 49(14):8370-8383. PubMed ID: 34244793
[TBL] [Abstract][Full Text] [Related]
9. LncRNA ZFAS1 promotes laryngeal cancer progression through RBFOX2-mediated MENA alternative splicing.
Lu B; Li X; Miao W; Liu Q; Li R; Cui C; Gao Q; Lian R
Environ Toxicol; 2023 Mar; 38(3):522-533. PubMed ID: 36336961
[TBL] [Abstract][Full Text] [Related]
10. RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing.
Maurin M; Ranjouri M; Megino-Luque C; Newberg JY; Du D; Martin K; Miner RE; Prater MS; Wee DKB; Centeno B; Pruett-Miller SM; Stewart P; Fleming JB; Yu X; Bravo-Cordero JJ; Guccione E; Black MA; Mann KM
Nat Commun; 2023 Dec; 14(1):8444. PubMed ID: 38114498
[TBL] [Abstract][Full Text] [Related]
11. The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion.
Braeutigam C; Rago L; Rolke A; Waldmeier L; Christofori G; Winter J
Oncogene; 2014 Feb; 33(9):1082-92. PubMed ID: 23435423
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Splicing Induced by Dysregulated Rbfox2 Produces Enhanced Function of Ca
Zhou Y; Fan J; Zhu H; Ji L; Fan W; Kapoor I; Wang Y; Wang Y; Zhu G; Wang J
Hypertension; 2017 Dec; 70(6):1183-1192. PubMed ID: 28993448
[TBL] [Abstract][Full Text] [Related]
13. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
[TBL] [Abstract][Full Text] [Related]
14. ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion.
Saulnier O; Guedri-Idjouadiene K; Aynaud MM; Chakraborty A; Bruyr J; Pineau J; O'Grady T; Mirabeau O; Grossetête S; Galvan B; Claes M; Al Oula Hassoun Z; Sadacca B; Laud K; Zaïdi S; Surdez D; Baulande S; Rambout X; Tirode F; Dutertre M; Delattre O; Dequiedt F
Nucleic Acids Res; 2021 May; 49(9):5038-5056. PubMed ID: 34009296
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing induces cytoplasmic localization of RBFOX2 protein in calcific tendinopathy.
Cho N; Kim JO; Lee S; Choi S; Kim J; Ko MS; Park SJ; Ji JH; Kim KK
Exp Mol Pathol; 2019 Aug; 109():36-41. PubMed ID: 31128090
[TBL] [Abstract][Full Text] [Related]
16. RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer.
Jbara A; Lin KT; Stossel C; Siegfried Z; Shqerat H; Amar-Schwartz A; Elyada E; Mogilevsky M; Raitses-Gurevich M; Johnson JL; Yaron TM; Ovadia O; Jang GH; Danan-Gotthold M; Cantley LC; Levanon EY; Gallinger S; Krainer AR; Golan T; Karni R
Nature; 2023 May; 617(7959):147-153. PubMed ID: 36949200
[TBL] [Abstract][Full Text] [Related]
17. Genes of the cGMP-PKG-Ca
Wan X; Belanger K; Widen SG; Kuyumcu-Martinez MN; Garg NJ
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165620. PubMed ID: 31778749
[TBL] [Abstract][Full Text] [Related]
18. The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma.
Holmes B; Benavides-Serrato A; Saunders JT; Landon KA; Schreck AJ; Nishimura RN; Gera J
J Neurooncol; 2019 Oct; 145(1):11-22. PubMed ID: 31473880
[TBL] [Abstract][Full Text] [Related]
19. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation.
Su IC; Su YK; Setiawan SA; Yadav VK; Fong IH; Yeh CT; Lin CM; Liu HW
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175412
[TBL] [Abstract][Full Text] [Related]
20. EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1-2 signaling.
Wei Y; Lu C; Zhou P; Zhao L; Lyu X; Yin J; Shi Z; You Y
Neuro Oncol; 2021 Apr; 23(4):611-624. PubMed ID: 32926734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
